Charles Schwab Investment Management Inc In8 Bio, Inc. Transaction History
Charles Schwab Investment Management Inc
- $519 Billion
- Q2 2024
A detailed history of Charles Schwab Investment Management Inc transactions in In8 Bio, Inc. stock. As of the latest transaction made, Charles Schwab Investment Management Inc holds 13,105 shares of INAB stock, worth $4,324. This represents 0.0% of its overall portfolio holdings.
Number of Shares
13,105
Previous 13,105
-0.0%
Holding current value
$4,324
Previous $15,000
26.67%
% of portfolio
0.0%
Previous 0.0%
Shares
1 transactions
Others Institutions Holding INAB
# of Institutions
27Shares Held
7.74MCall Options Held
0Put Options Held
0-
Aigh Capital Management LLC Baltimore, MD2.13MShares$702,2390.66% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.42MShares$469,8860.0% of portfolio
-
Ensign Peak Advisors, Inc Salt Lake City, UT1.12MShares$369,0270.0% of portfolio
-
Alyeska Investment Group, L.P. Chicago, IL641KShares$211,5320.0% of portfolio
-
Sigma Planning Corp Ann Arbor, MI600KShares$197,8940.02% of portfolio
About IN8BIO, INC.
- Ticker INAB
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 24,502,200
- Market Cap $8.09M
- Description
- IN8bio, Inc., a clinical-stage biotechnology company, focuses on the discovery, development, and commercialization of gamma-delta T cell therapies for the treatment of cancers. Its lead product candidate includes INB-200, a genetically modified autologous gamma-delta T cell product candidate that is in Phase I clinical trial for the treatment of...